https://www.technologynetworks.com/drug-discovery/news/successful-completion-of-investigational-japanese-encephalitis-vaccine-study-210735
Intercell AG and its partner Biological E. Ltd. announce the successful completion of a pediatric Phase II/III study for the vaccine to protect children from...
japanese encephalitis vaccinestudy technologysuccessfulcompletionnetworks